Overview
This is the prospective, observational cohort study (Radiogenomics-Urinary), which aims to explore the relationship between the imaging information of urologic cancer patients, tumor microenvironment and the prognosis of urologic cancer patients.
Eligibility
Inclusion Criteria:
- Patients treated for urologic cancer in Wuhan Union Hospital from August 2024 to August 2027;
- Aged > 18 years old;
- At least one CT scan or MRI scan before treatment;
- Tissue biopsy pathological examination confirmed the diagnosis of the above tumors.
Exclusion criteria：
- Poor image quality;
- Incomplete clinical data or loss of follow-up;
- Presence of another primary malignancy other than urologic cancer;
- Unclear pathological diagnosis。